This section contains press releases and other materials from third parties (including paid content). JOBFlocks has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on NA Companies: Microsoft (MSFT) and Scholar Rock Holding (SRRK)

Tipranks - Wed Oct 14, 7:26AM CDT

There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Microsoft (MSFT) and Scholar Rock Holding (SRRK) with bullish sentiments.

Microsoft (MSFT)

J.P. Morgan analyst Samik Chatterjee maintained a Buy rating on Microsoft today and set a price target of $625.00. The company’s shares closed last Monday at $541.15.

According to TipRanks.com, Chatterjee is a top 25 analyst with an average return of 56.7% and a 76.6% success rate. Chatterjee covers the Technology sector, focusing on stocks such as Zoom Communications Inc, Dell Technologies, and Vistance Networks. ;'>

Currently, the analyst consensus on Microsoft is a Strong Buy with an average price target of $588.56, representing a 9.5% upside. In a report issued on October 6, Yorkville Ives & Co also initiated coverage with a Buy rating on the stock with a $615.00 price target.

See today’s best-performing stocks on TipRanks >>

Scholar Rock Holding (SRRK)

In a report released today, Srikripa Devarakonda from Truist Financial reiterated a Buy rating on Scholar Rock Holding, with a price target of $77.00. The company’s shares closed last Monday at $41.94, close to its 52-week high of $46.98.

According to TipRanks.com, Devarakonda is a 5-star analyst with an average return of 24.7% and a 56.8% success rate. Devarakonda covers the Healthcare sector, focusing on stocks such as NewAmsterdam Pharma Company, Madrigal Pharmaceuticals, and Protagonist Therapeutics. ;'>

Currently, the analyst consensus on Scholar Rock Holding is a Strong Buy with an average price target of $69.81, representing a 66.5% upside. In a report issued on October 6, TipRanks – Google also reiterated a Buy rating on the stock with a $49.00 price target.

Read More on MSFT:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.